Long-Time Horizon Analysis of Bristol-Myers Squibb Co (BMY) Stock

Bristol-Myers Squibb Co [BMY] stock is trading at $47.00, down -1.82%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BMY shares have gain 6.53% over the last week, with a monthly amount drifted -5.66%, and not seem to be holding up […]

Are Bristol-Myers Squibb Co (BMY) stocks a prudent buy?

At the time of writing, Bristol-Myers Squibb Co [BMY] stock is trading at $49.61, down -1.18%. An important factor to consider is whether the stock is rising or falling in short-term value. The BMY shares have gain 1.89% over the last week, with a monthly amount drifted -16.69%, and not seem to be holding up […]

Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval

Bristol-Myers Squibb [NYSE: BMY] declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or refractory large B-cell lymphoma. Breyazni is a CAR T cell Therapy. This therapy is a ray of hope for the victims experiencing relapsed or refractory large B-cell lymphoma. The authorization […]

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.